HWM
Hohimer Wealth Management’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $352K | Buy |
1,896
+1
| +0.1% | +$186 | 0.06% | 173 |
|
2025
Q1 | $397K | Buy |
1,895
+359
| +23% | +$75.2K | 0.08% | 177 |
|
2024
Q4 | $273K | Buy |
1,536
+104
| +7% | +$18.5K | 0.05% | 189 |
|
2024
Q3 | $283K | Buy |
1,432
+160
| +13% | +$31.6K | 0.06% | 176 |
|
2024
Q2 | $218K | Sell |
1,272
-1
| -0.1% | -$172 | 0.05% | 202 |
|
2024
Q1 | $232K | Buy |
+1,273
| New | +$232K | 0.05% | 210 |
|
2023
Q1 | – | Sell |
-25,683
| Closed | -$4.15M | – | 195 |
|
2022
Q4 | $4.15M | Buy |
25,683
+3,889
| +18% | +$629K | 1.32% | 18 |
|
2022
Q3 | $2.93M | Buy |
21,794
+327
| +2% | +$43.9K | 0.94% | 38 |
|
2022
Q2 | $3.29M | Sell |
21,467
-10,889
| -34% | -$1.67M | 0.97% | 38 |
|
2022
Q1 | $5.25M | Buy |
32,356
+1,457
| +5% | +$236K | 1.03% | 24 |
|
2021
Q4 | $4.18M | Buy |
30,899
+19
| +0.1% | +$2.57K | 0.88% | 30 |
|
2021
Q3 | $3.33M | Buy |
30,880
+626
| +2% | +$67.5K | 0.7% | 54 |
|
2021
Q2 | $3.41M | Buy |
30,254
+1,856
| +7% | +$209K | 0.7% | 55 |
|
2021
Q1 | $3.07M | Buy |
28,398
+2,842
| +11% | +$308K | 0.75% | 45 |
|
2020
Q4 | $2.74M | Buy |
25,556
+311
| +1% | +$33.3K | 0.73% | 41 |
|
2020
Q3 | $2.13M | Sell |
25,245
-436
| -2% | -$36.8K | 0.61% | 51 |
|
2020
Q2 | $2.52M | Sell |
25,681
-1,626
| -6% | -$160K | 0.87% | 33 |
|
2020
Q1 | $2.31M | Buy |
27,307
+5,005
| +22% | +$424K | 0.98% | 27 |
|
2019
Q4 | $1.98M | Buy |
+22,302
| New | +$1.98M | 0.69% | 43 |
|